Mycoplasma Testing Market was
valued at USD 446.9 million in 2016 and is anticipated to witness a lucrative
growth over the forecast period. Rising number of pharmaceutical and
biopharmaceutical companies, increasing R&D investment, and growing number
of drug launches are major attributes that are fuelling the market.
Increase in the number of biopharmaceutical and
pharmaceutical companies has been seen in the past years. This growth has been
attributed by the need for advanced drugs and therapies for the treatment of
chronic diseases like cancer, diabetes, cardiovascular diseases and osteoporosis
among others. The research work is supported by the government by funding the
pharmaceutical and biotechnology companies in order to facilitate research
based activities for the development of new drugs. This may foster the growth
of mycoplasma testing market.
Request Sample Copy
of this Market Research @ https://www.millioninsights.com/industry-reports/mycoplasma-testing-market/request-sample
Rising investment in R&D by dominant players has further
resulted in growth of the market. In the year 2016, North America spent 28.4%
of its GDP on research and development according to Global R&D Funding
Forecast. This signifies significant rise in the spending by various companies
for the invention of new and enhanced testing devices and kits. With the
growing expenditure by the government in the healthcare industry and awareness
campaigns have led to the growth of the mycoplasma testing market. Mycoplasma
testing is conducted so as to ensure the product is contamination free during
each stage of manufacturing process.
Mycoplasma contamination is a major cause of concern in
research and development activities. Infections caused by M. orale or M.
fermentans are strains that frequently are seen in humans are a key source of
contamination in laboratory settings. These contaminations in cell cultures
cause morphological changes, altered cell metabolism and chromosomal
aberrations causing contamination in the entire cell line. Contamination may
also result in serious complications such as pneumonia, genital infections and
other respiratory disorders is also seen. Thus, to prevent such contaminations,
mycoplasma testing is vital.
Product Insights
Based on the products, the market is segmented into kits,
reagents, instruments, and services. Kits & reagents segment holds the
largest market share owing to its repetitive purchase. Kits & reagents
segment has been studied after further sub-segmentation into- nucleic acid
detection kits, elimination kits, PCR assays, stains, and standards &
controls.
Browse Full Research
Report @ https://www.millioninsights.com/industry-reports/mycoplasma-testing-market
Market Segment:
Mycoplasma Testing
Product Outlook (Revenue, USD Million, 2014 - 2025)
• Instruments
• Kits &
Reagents
• PCR
Assays
•
Nucleic Acid Detection Kits
•
Stains
•
Elimination Kits
•
Standards & Controls
•
Others
• Services
Mycoplasma Testing
Technology Outlook (Revenue, USD Million, 2014 - 2025)
• PCR
• ELISA
• Direct Assay
• Indirect
Assay
• Microbial
Culture Techniques
• Enzymatic
Methods
Mycoplasma Testing Application
Outlook (Revenue, USD Million, 2014 - 2025)
• Cell Line
Testing
• Virus
Testing
• End of
Production Cells Testing
• Others
For More Details
Please Visit www.millioninsightsmarket.wordpress.com
No comments:
Post a Comment